NCT03365388

A Validation Study of Sodium Hyaluronate in Patients With Periarthritis of Shoulder

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 260 (estimated)
• Sponsor: Peking University People's Hospital · Academic / Other
• Sex: All
• Age: 35 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Alge as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate

Detailed description

Aerzhi as a positive control drug, in patients with periarthritis of shoulder, in a double-blind, controlled manner to study the safety and treatment of Sodium Hyaluronate. Once a week, continuous treatment for 5 weeks

Conditions

• Periarthritis

Interventions

Type	Name	Description
DRUG	Sodium Hyaluronate	Hyaluronic acid is a component of synovial fluid. N- is glucuronic acid and N-acetylglucosamine repeating disaccharide unit form
DRUG	Aerzhi	Sodium Hyaluronate Injection can cover and protect joint tissue, improve lubrication function, and penetrate degenerative cartilage

Timeline

• Start date: 2018-04-01
• Primary completion: 2020-04-01
• Completion: 2020-04-01
• First posted: 2017-12-07
• Last updated: 2017-12-07

Locations

1 site across 1 country: China